Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases
<p>Abstract</p> <p>Objective</p> <p>To determine plasma apolipoprotein M (apoM) levels and other lipid profiles in hepatocellular carcinoma (HCC) patients compared to other chronic liver diseases and normal subjects.</p> <p>Materials and methods</p> &l...
Main Authors: | Li Min, Xu Bin, Lu Minyang, Deng Haifeng, Luo Guanghua, Qin Xihu, Wu Changping, Zhang Xiaoying, Jiang Jingting, Ji Mei, Xu Ning |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-07-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/7/1/25 |
Similar Items
-
A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
by: Stefan Hajny, et al.
Published: (2017-07-01) -
Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01) -
Plasma Apolipoprotein-M (ApoM) Response to a Circuit Resistance Training Program
by: Abbass Ghanbari-Niaki
Published: (2013-12-01) -
Correlation research of serum APoM contents with disease activity for SLE patients
by: Kuo Shen, et al.
Published: (2017-07-01) -
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
by: Christina Christoffersen, et al.
Published: (2012-10-01)